(Q34543317)

2 August 2017

Permeability of the blood-brain barrier for atenolol studied by positron emission tomography (English)

1 reference

2 August 2017

1 reference

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB03545.X

27 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB03545.X

27 October 2022

author name string

P. Agon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1681079

27 October 2022

P. Goethals

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1681079

27 October 2022

D. Van Haver

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1681079

27 October 2022

J. M. Kaufman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1681079

27 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1681079

27 October 2022

publication date

1 August 1991

1 reference

full work available at URL

2 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.2042-7158.1991.tb03545.x

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB03545.X

http://academic.oup.com/jpp/article-pdf/43/8/597/37241001/j.2042-7158.1991.tb03545.x.pdf

27 October 2022

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB03545.X

Journal of Pharmacy and Pharmacology

27 October 2022

published in

1 reference

2 August 2017

43

1 reference

2 August 2017

8

1 reference

2 August 2017

597-600

1 reference

describes a project that uses

2 August 2017

positron emission tomography

1 reference

based on heuristic

inferred from title

cites work

Drug distribution in dog brain studied by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1991.TB03545.X

Study with positron emission tomography of the osmotic opening of the dog blood-brain barrier for quinidine and morphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1991.TB03545.X

Selection of experimental conditions for the accurate determination of blood--brain transfer constants from single-time experiments: a theoretical analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1991.TB03545.X

The clinical importance of cardioselectivity and lipophilicity in beta blockers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1991.TB03545.X

Cardiovascular effects of beta-adrenoreceptor blocking agents after intracerebroventricular administration in conscious normotensive cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1991.TB03545.X

The central uptake of beta-adrenoceptor antagonists [proceedings]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1991.TB03545.X

Lipophilicity, hydrophilicity, and the central nervous system side effects of beta blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1991.TB03545.X

Psychotropic effects of repeated doses of enalapril, propranolol and atenolol in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1991.TB03545.X

Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1991.TB03545.X

Beta-blockers and central nervous system side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1991.TB03545.X

Beta-adrenoceptor blockers and the blood-brian barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1991.TB03545.X

Disposition and Metabolism of Atenolol in Animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1991.TB03545.X

Cerebrospinal fluid concentrations of propranolol, pindolol and atenolol in man: evidence for central actions of beta-adrenoceptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1991.TB03545.X

A pharmacokinetic analysis program (multi) for microcomputer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1991.TB03545.X

Central nervous system kinetics of atenolol and metoprolol in the dog during long term treatment

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB03545.X

Protein binding of atenolol and propranolol to human serum albumin and in human plasma [proceedings]

27 October 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB03545.X

beta-Adrenoreceptor-blocking agents and the blood-brain barrier

27 October 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB03545.X

Tissue atenolol levels following chronic beta-adrenoceptor blockade using oral atenolol in dogs

27 October 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB03545.X

Performance evaluation of a positron tomograph designed for brain imaging

27 October 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB03545.X

Clinical pharmacokinetics of atenolol

27 October 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB03545.X

An investigation of the comparative liposolubilities of β-adrenoceptor blocking agents

27 October 2022

31

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB03545.X

27 October 2022

Identifiers

1 reference

2 August 2017

1 reference